Table 3.
Metabolite | b̂ | SE | 95% CI for b̂ | p (pFDR) |
---|---|---|---|---|
Severity of ideation | ||||
Glu | 2.486 | 1.644 | −0.863 to 5.834 | 0.140 (0.187) |
Glx | 5.653 | 2.518 | 0.518 to 10.788 | 0.032 (0.064) |
NAA | −0.262 | 0.936 | −2.168 to 1.644 | 0.781 (0.781) |
NAA/Glx | −0.044 | 0.014 | −0.072 to −0.016 | 0.003 (0.012) |
Intensity of ideation | ||||
Glu | 0.655 | 0.403 | −0.167 to 1.476 | 0.114 (0.152) |
Glx | 1.603 | 0.607 | 0.365 to 2.841 | 0.013 (0.026) |
NAA | −0.014 | 0.231 | −0.484 to 0.457 | 0.952 (0.952) |
NAA/Glx | −0.012 | 0.003 | −0.018 to −0.005 | 0.001 (0.004) |
Multiple linear regressions examining relationships of suicidal ideation severity and intensity with 1H-MRS-measured ACC metabolites. Regression models include sex, age at scan, psychotropic medication use, and depression severity (adjusted CDRS-R total score). The unstandardized parameter estimate (coefficient) for the SI variable (b̂), standard error of b̂, 95% confidence intervals for b̂, and p-values for the regression relationship between the suicidal ideation variable and the ACC metabolite are reported.
1H-MRS proton magnetic resonance spectroscopy, CI confidence interval, Glu glutamate, Glx glutamate+glutamine, NAA N-acetylaspartate, pFDR p-value adjusted for multiple comparisons according to the false-discovery rate procedure59, SE standard error.